43 related articles for article (PubMed ID: 3134521)
1. Further characterization of malignant glioma-derived vascular permeability factor.
Criscuolo GR; Merrill MJ; Oldfield EH
J Neurosurg; 1988 Aug; 69(2):254-62. PubMed ID: 3134521
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor concentrations in the cerebrospinal fluid of dogs with neoplastic or inflammatory central nervous system disorders.
Mariani CL; Niman ZE; Boozer LB; Ruterbories LK; Early PJ; Muñana KR; Olby NJ
J Vet Intern Med; 2021 Jul; 35(4):1873-1883. PubMed ID: 34105831
[TBL] [Abstract][Full Text] [Related]
3. Vascular hyperpermeability as a hallmark of phacomatoses: is the etiology angiogenesis related to or comparable with mechanisms seen in inflammatory pathways? Part II: angiogenesis- and inflammation-related molecular pathways, tumor-associated macrophages, and possible therapeutic implications: a comprehensive review.
Laviv Y; Kasper B; Kasper EM
Neurosurg Rev; 2018 Oct; 41(4):931-944. PubMed ID: 28283837
[TBL] [Abstract][Full Text] [Related]
4. Systemic Expression of Vascular Endothelial Growth Factor in Patients with Cerebral Cavernous Malformation Treated by Stereotactic Radiosurgery.
Park SJ; Park SH
J Korean Neurosurg Soc; 2016 Sep; 59(5):442-8. PubMed ID: 27651861
[TBL] [Abstract][Full Text] [Related]
5. VEGF -634C/G genotype is predictive of long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
Tamura T; Kuwahara A; Yamamori M; Nishiguchi K; Nakamura T; Okuno T; Miki I; Manabe Y; Sakaeda T
Int J Med Sci; 2012; 9(10):833-7. PubMed ID: 23155356
[TBL] [Abstract][Full Text] [Related]
6. Bevacizumab and intraocular tumors: an intriguing paradox.
el Filali M; Ly LV; Luyten GP; Versluis M; Grossniklaus HE; van der Velden PA; Jager MJ
Mol Vis; 2012; 18():2454-67. PubMed ID: 23077404
[TBL] [Abstract][Full Text] [Related]
7. Cytokine and growth factor responses after radiotherapy for localized ependymoma.
Merchant TE; Li C; Xiong X; Gaber MW
Int J Radiat Oncol Biol Phys; 2009 May; 74(1):159-67. PubMed ID: 19019565
[TBL] [Abstract][Full Text] [Related]
8. VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese.
Yamamori M; Taniguchi M; Maeda S; Nakamura T; Okamura N; Kuwahara A; Iwaki K; Tamura T; Aoyama N; Markova S; Kasuga M; Okumura K; Sakaeda T
Int J Med Sci; 2008 Apr; 5(2):80-6. PubMed ID: 18414651
[TBL] [Abstract][Full Text] [Related]
9. The role of VEGF receptors in angiogenesis; complex partnerships.
Cébe-Suarez S; Zehnder-Fjällman A; Ballmer-Hofer K
Cell Mol Life Sci; 2006 Mar; 63(5):601-15. PubMed ID: 16465447
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis factors in gliomas: a new key to tumour therapy?
Mentlein R; Held-Feindt J
Naturwissenschaften; 2003 Sep; 90(9):385-94. PubMed ID: 14504780
[TBL] [Abstract][Full Text] [Related]
11. Regulation of microvascular permeability by vascular endothelial growth factors.
Bates DO; Hillman NJ; Williams B; Neal CR; Pocock TM
J Anat; 2002 Jun; 200(6):581-97. PubMed ID: 12162726
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.
Vaquero J; Zurita M; Morales C; Cincu R; Oya S
J Neurooncol; 2000 Aug; 49(1):49-55. PubMed ID: 11131986
[TBL] [Abstract][Full Text] [Related]
13. Vascular permeability factor expression in cerebellar hemangioblastomas: correlation with tumor-associated cysts.
Vaquero J; Zurita M; Oya S; Coca S; Salas C
J Neurooncol; 1999 Jan; 41(1):3-7. PubMed ID: 10222417
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor.
Plate KH; Warnke PC
J Neurooncol; 1997 Dec; 35(3):365-72. PubMed ID: 9440033
[TBL] [Abstract][Full Text] [Related]
15. Clinical neurosciences in the decade of the brain: hypotheses in neuro-oncology. VEG/PF acts upon the actin cytoskeleton and is inhibited by dexamethasone: relevance to tumor angiogenesis and vasogenic edema.
Criscuolo GR; Balledux JP
Yale J Biol Med; 1996; 69(4):337-55. PubMed ID: 9273988
[TBL] [Abstract][Full Text] [Related]
16. Glial ontogeny and glial neoplasia: the search for closure.
Linskey ME
J Neurooncol; 1997 Aug; 34(1):5-22. PubMed ID: 9210049
[TBL] [Abstract][Full Text] [Related]
17. Involvement of vascular endothelial growth factor in Kaposi's sarcoma associated with acquired immunodeficiency syndrome.
Sakurada S; Kato T; Mashiba K; Mori S; Okamoto T
Jpn J Cancer Res; 1996 Nov; 87(11):1143-52. PubMed ID: 9045943
[TBL] [Abstract][Full Text] [Related]
18. Reversion of phenotype of endothelial cells in brain tissue around glioblastomas.
Vaz R; Borges N; Sarmento A; Azevedo I
J Neurooncol; 1996 Feb; 27(2):127-32. PubMed ID: 8699234
[TBL] [Abstract][Full Text] [Related]
19. Neuropathological and neurophysiological effects of interstitial white matter autologous and non-autologous protein containing solutions: further evidence for a glioma derived permeability factor.
Whittle IR; Ironside JW; Piper IR; Miller JD
Acta Neurochir (Wien); 1993; 120(3-4):164-74. PubMed ID: 8460570
[TBL] [Abstract][Full Text] [Related]
20. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms.
Berkman RA; Merrill MJ; Reinhold WC; Monacci WT; Saxena A; Clark WC; Robertson JT; Ali IU; Oldfield EH
J Clin Invest; 1993 Jan; 91(1):153-9. PubMed ID: 8380810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
